Definitive Contract HDTRA118C0014
- Not listed
- This is a $3,000,000.00 firm fixed price contract awarded to Quantitative Biosciences, Inc. by the Defense Threat Reduction Agency (DTRA), a defense agency, to develop a compact microfluidic biosensor. The contract has a total small business set-aside designation and is scheduled for completion by November 13, 2017. Quantitative Biosciences, Inc. is a for-profit company that specializes in customized biosensor development for applications such as water quality monitoring. In addition to this...
- This is a cost plus fixed fee contract awarded by the Defense Threat Reduction Agency (DTRA), a defense agency, to Bioprotection Systems Corporation, a for-profit organization. The contract, with an award value of $1,626,740.14, is for the base period and does not have a set-aside designation. The contract was awarded on March 22, 2016, with an ultimate completion date of March 21, 2019. The place of performance is Ames, Iowa. The contract type is a definitive contract with a pricing type of...
- This is a federal contract award from the Defense Threat Reduction Agency (DTRA), a defense agency, to Memed Diagnostics LTD, a for-profit limited liability company located in Israel. The contract has a ceiling value of $10,373,294.17 and is a cost-plus-fixed-fee definitive contract with a period of performance ending on September 30, 2020. The contract was awarded on January 1, 2017 and was not set aside. The purpose of the contract is not provided, but DTRA's mission is to counter and deter...
- This is a $1,271,417.59 Cost Plus Fixed Fee contract awarded by the Defense Threat Reduction Agency (DTRA), a defense agency, to Genecapture, Inc., a for-profit startup company. The contract is for a Small Business Technology Transfer (STTR) Phase II effort focused on developing infectious disease diagnostics and differentiation of viral versus bacterial infections for point-of-care applications. The contract was set aside for small businesses. Genecapture specializes in rapid infectious disease...
- This is a Cost Plus Fixed Fee contract awarded by the Defense Threat Reduction Agency (DTRA) to Teledyne Flir Defense, Inc., a subsidiary of Teledyne Technologies Incorporated, for the development of digital battlefield chemical and biological threat mapping and augmented reality display capabilities. The $25,567,855.01 contract has an ultimate completion date of December 31, 2025 and was awarded on September 24, 2021 under a Broad Agency Announcement (BAA) that seeks research and development...
- This federal contract award was issued by the Defense Threat Reduction Agency (DTRA) to Battelle Memorial Institute, a large nonprofit research and development organization, for advanced threats research, development, test, and evaluation related to chemical, biological, radiological, and nuclear (CBRN) defense. The $77.48 million cost-plus-fixed-fee contract has a completion date of March 29, 2027. The contract includes multiple subcontractors providing specialized equipment, forensic...
- This federal contract award, HDTRA215P0007, was made by the Defense Threat Reduction Agency (DTRA) to Biofire Defense LLC, a limited liability company that manufactures biological agent identification products. The $254,100.00 firm fixed price purchase order is for a RAZR-ASY-4001 Bioterrorism Detection System with a one-year extended warranty, under Product Service Code (PSC) 6630. This award does not have a set-aside designation. Biofire Defense LLC has previously received other federal...
- This is a $149,877.00 firm fixed price purchase order awarded by the Defense Threat Reduction Agency (DTRA) to Radiant Genomics, Inc., a small disadvantaged business. The contract is for a SBIR Phase I research project. SBIR stands for Small Business Innovation Research, which is a program that provides funding for small businesses to conduct research and development. The contract has a total small business set-aside, meaning it was reserved for small businesses. The period of performance ends...
- This is a federal contract award from the Defense Threat Reduction Agency (DTRA), a defense agency, to Nanobiosym Inc., a for-profit woman-owned small business. The contract, valued at $2,050,000.00, is for a base period with no set-aside designation. The contract type is a definitive contract with cost-no-fee pricing. The place of performance is East Cambridge, Massachusetts. Nanobiosym Inc. has been awarded federal contracts and grants in the past. Without additional details on the original...
- This is a $5,475,084.69 cost-plus-fixed-fee definitive contract awarded by the Defense Threat Reduction Agency (DTRA) to Teledyne Flir Defense, Inc., a subsidiary of Teledyne Technologies Incorporated. The contract is for "SMART DEVICES FOR IMPROVED AGENT DISCLOSURE OPERATIONAL UTILITY AND CONTAMINATION MAPPING" and has an ultimate completion date of August 16, 2022. The contract is not designated as a set-aside. Teledyne Flir Defense, Inc. is a sophisticated technology provider...
This is a federal contract award from the Defense Threat Reduction Agency (DTRA), a defense agency, to Optical Biosystems, Inc., a for-profit manufacturer, for a "Rapid Quantitative In-Situ Protein and Gene Expression Platform Technologies for Host Response Biomarker Methods and Analysis" project. The contract is a Definitive Contract with a Cost Plus Fixed Fee pricing type, has a ceiling value of $4,487,101.00, and was awarded on December 7, 2017 with an ultimate completion date of December 6, 2020. The contract is an Undefinitized Order and does not have a set-aside designation. This award appears to be for the development and delivery of biomarker analysis technologies to support DTRA's mission in the area of defense against chemical, biological, radiological, and nuclear threats.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| A00001 | Other Administrative Action | ($11k) | 6/24/25 | |
| P00003 | Exercise an Option | $1.6m | 11/29/18 | |
| P00002 | Funding Only Action | $719.1k | 5/22/18 | |
| P00001 | Funding Only Action | $430.0k | 3/27/18 | |
| Not listed | Not listed | $289.1k | 12/7/17 |